Beibei Chen

Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania.

Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.

UPMC Enterprises (UPMC Enterprises) is a venture capital subsidiary of University of Pittsburgh Medical Center founded in 2014. The firm is headquartered in Pittsburgh, Pennsylvania.

Novasenta, Inc. develops therapies for cancer. The company is based in Pittsburgh, PA. The company was founded by Greg Delgoffe, Robert L. Ferris, Dario Vignali. Mani Mohindru has been the CEO of the company since 2021.

Founded in 2002, PLSG Capital Investment Programs is a venture capital/private equity firm located in Pittsburgh, Pennsylvania.

Inspired Technologies, Inc. develops and supplies personal oxygen systems for patients. It provides personal oxygen portables based on SmartDose technology that continuously monitors the user’s breath rate and automatically adjusts the oxygen dose to the user’s activity level; and clinical oxygen dose recorders that enables to view patient response and conserver performance in real time. The firm also offers Viaspire SD Card Software, a software utility to upload and view patient data from SD Cards in SmartDose oxygen dosing units. The company was founded by Dan Easley in May 2005 and is headquartered in North Huntingdon, PA.

Protez Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It develops antibiotics for infections & provides research service on intravenous & oral small molecule antibiotics to chronic and recurrent infections. The company was founded by Klaus Esser, Luigi Xerri & Christopher M. Cashman in 2003 and is headquartered in Malvern, PA.

Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States.

IDEV Technologies, Inc. develops medical devices for endovascular uses. Its products include interventional cardiology, interventional radiology and vascular surgery. The company was founded by Sheldon J. Jeffery in 1999 and is headquartered in Webster, TX.

BlueSphere Bio, Inc. manufactures oncology drugs products. The company was founded by Mark Shlomchik, Warren Shlomchik, and Constantinos Panousis and is headquartered in Pittsburgh, PA.

ALung Technologies, Inc. engages in the provision of respiratory support solutions. The company was founded by William Federspiel and Brack Hattler in 1997 and is headquartered in Pittsburgh, PA.

Globin Solutions, Inc. operates as a pre-clinical stage biopharmaceutical company. It researches and develops a rapidly acting antidote for carbon monoxide poisoning. The company was founded by Mark T. Gladwin, Jack D. Myers, Jason J. Rose and Jesus Tejero Bravo in 2017 and is headquartered in Pittsburgh, PA.

SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France.

University of Pittsburgh Medical Center is a non-profit organization, which engages in the provision of hospital health programs and services. It operates through the following business units: Provider Services, Insurance Services, UPMC International, and UPMC Enterprises. It also develops programs in transplantation, cancer, neurosurgery, psychiatry, orthopedics, and sports medicine. The company was founded in 1893 and is headquartered in Pittsburgh, PA.

Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities.

The Multiple Sclerosis Society is an organization that aims to find treatments for everyone affected by multiple sclerosis. The non-profit company is based in London, UK. The British company offers award-winning publications, factsheets, and booklets through their online shop. The society conducts surveys to shape the future direction of MS research, with the latest survey held in 2022 with over 6,500 participants. The company's current focus is on the STARMS trial, which compares HSCT with other highly effective treatments for relapsing MS. The treatment involves using chemotherapy to remove harmful immune cells and regrow the immune system using the patient's own stem cells. Nick Moberly has been the CEO of the company since 2019.

Pittsburgh Life Sciences Green House (PLSG) is a venture capital firm founded in 2002. The firm is headquartered in Pittsburgh, Pennsylvania.

Brainstage, Inc. provides technologies for healthcare and drug development. It acquires, develops, aggregates, and commercializes technologies within the healthcare field. The company was founded by Anthony A. Florence Jr. and Donald Doherty in 2007 and is headquartered in Carnegie, PA.

OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ.

Ariel Precision Medicine, Inc. provides integrated genomics and digital health services. It offers precision medicine solutions for the diagnosis, monitoring, and treatment of complex chronic diseases and disorders. The company was founded by David Whitcomb and Jessica M. Gibson and is headquartered in Pittsburgh, PA.

Birchmere Ventures Inc (Birchmere Ventures) is a venture capital firm founded in the year 1996 by Ned Renzi and Sean Sebastian. The firm is headquartered in Pittsburgh, Pennsylvania with an additional office in San Francisco.

L.E.K. Consulting is a global strategy consulting firm that specializes in corporate strategy, transaction services, and performance improvement. Founded in 1983, L.E.K. currently employs over 900 professionals in 20 offices worldwide. Global clients include Fortune 500, FTSE 100, Eurotop 300, and many of the largest firms in Asia-Pacific. With a reputation for solving the most complex issues, L.E.K. collaborates with business leaders to accelerate the pace and precision of strategic decision-making.